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Statement
Based on the epidemiologic data available and on cur-
rent knowledge of interactive mechanisms, there is
insufficient justification to warrant a conclusion of a
causal relationship between diagnostic ultrasound and
recognized adverse effects in humans. Some studies
have reported effects of exposure to diagnostic ultra-
sound during pregnancy, such as low birth weight,
delayed speech, dyslexia, and non–right-handedness.
Other studies have not demonstrated such effects. The
epidemiologic evidence is based on exposure condi-
tions prior to 1992, the year in which acoustic limits of
ultrasound machines were substantially increased for
fetal/obstetric applications.1
Rationale and Discussion
Epidemiology is the study of health and disease among groups
or populations. This includes analysis of causes and outcomes
of diseases and effects thereof among many individuals.
Applied to ultrasound, it is the study of its effects on human
populations as a result of ultrasound scanning. In the case of
obstetric ultrasound, this should include the pregnant patient
as well as her fetus. Laboratory animal experiments under
diagnostic exposure levels have shown some effects from ultra-
sound, under certain conditions. However, a definitive state-
ment regarding risk should, ideally, include direct analysis of
the effects in human populations. Basic concepts necessary to
analyze epidemiologic (or other) studies adequately include
measures of disease frequency (prevalence and incidence),
study design (observational or experimental), measures of
association (relative risk [RR] and odds ratio [OR]), bias, and
statistical precision (power and errors). For a more complete
discussion, see “Appendix.”
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Commentary
There is a paucity of rigorously conducted epi-
demiologic studies to evaluate adverse outcomes
of ultrasound. A number of studies of the use of
ultrasound in pregnancy, including some case-
control and prospective randomized control
studies, have been performed over the last 30
years. Occasional studies report an association
between diagnostic ultrasound and some specif-
ic abnormalities such as low birth weight,2
delayed speech,3 dyslexia,4 and non–right-hand-
edness.5 With the exception of low birth weight
(also shown in monkeys6), these findings have
never been duplicated, and most studies have
had negative findings for any association.
Caution in interpreting case-control studies is
essential because the effect being studied (eg,
low estimated weight) may be the reason for per-
forming the ultrasound examination and may
thus be found to be associated with it but not
through a causal relationship. There have been
several major reviews published of epidemiolog-
ic studies conducted over more than 25 years.7–11
Some of the studies had serious limitations, such
as small samples, poorly matched controls, and
absence of information on acoustic output and
quantification of exposure (number of episodes,
duration, and “dose” delivered to a particular tar-
get). This is particularly relevant in today’s clini-
cal situations because of the addition of new
modalities with potentially very high energy lev-
els (such as spectral Doppler imaging) and the
expansion of diagnostic studies to the first
trimester, which is known to be a period of high
sensitivity of the fetus to teratologic insults.
More recent studies suggest an association
between ultrasound exposure during pregnancy
and non–right-handedness in male neonates.
However, methodological questions exist.12,13
Low Birth Weight
Because several animal studies have described,
albeit not always convincingly, that ultrasound
may cause birth weight reduction, the question
of possible effects in humans has been raised.
The mechanism whereby a fall in somatic growth
would be induced by ultrasound is unclear, but
tissue heating and effects on insulin growth fac-
tors and heat shock proteins have been consid-
ered.14 Decreased birth weight after prenatal
exposure to ultrasound has been reported in the
monkey6 and the mouse15,16 but not the rat.17 In
situ intensities were higher than what is consid-
ered routine in clinical obstetric imaging in the
human. High-level exposures were associated
with decreased body weight at birth in exposed
animals compared with controls, but all showed
catch-up growth when examined at 3 months of
age.6 Among retrospective studies in humans,
one8 showed birth weight reduction (116 g at
term). Another retrospective study, with Moore
as a coauthor, reported a 2.0 greater risk of low
birth weight after 4 or more exposures to diag-
nostic ultrasound.18 These results were not repro-
duced in other retrospective studies.7,19 Several
randomized studies did not show any ill effect of
1 or 2 prenatal scans on growth.20,21 In fact, in sev-
eral studies, birth weight was slightly higher in
the scanned group, but not significantly so,20,22
except in one.23 The only randomized study that
reports a difference with a higher proportion of
small-for-gestational-age neonates suggests that
multiple scans (5, including Doppler flow stud-
ies) may produce some decrease in birth weight,
possibly via an effect on bone growth.2 However,
when children from the last-mentioned study
were examined at 1 year of age, there were no dif-
ferences between the study and control groups.24
Overall, the available evidence suggests that rou-
tine diagnostic prenatal scanning does not affect
birth weight. It is important to remember that all
existing epidemiologic data are based on studies
using 94 mW/cm2 as the upper limit.
Delayed Speech
In an attempt to determine whether there is an
association between prenatal ultrasound expo-
sure and delayed speech in children, Campbell et
al3 studied the clinical records of 72 children who
had undergone a formal speech-language evalu-
ation and were found to have delayed speech of
unknown cause. For each subject, 2 control sub-
jects were matched for sex, date of birth, sibling
birth order, and associated health problems. The
72 children with delayed speech were found to
have a higher rate of ultrasound exposure in
utero than the 144 control subjects (OR, 2.8; 95%
confidence interval [CI], 1.5–5.3; P = .001). There
was neither a dose-response effect nor any rela-
tionship to time of exposure. Many of the records
were more than 5 years old. Confounding is a
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serious problem in such a study, in that the con-
ditions prompting the performance of an ultra-
sound examination during pregnancy may affect
the likelihood of delayed speech.
In a later study, Salvesen et al25 compared the
incidence of delayed speech in 1107 children who
had been exposed in utero with 1033 controls.
They found no significant differences in delayed
speech, limited vocabulary, or stuttering. Children
who were exposed to ultrasound in utero were less
likely to be referred to a speech therapist.
Because of the many weaknesses in the study
by Campbell et al,3 the absence of any credible
mechanism for an association of in utero ultra-
sound exposures, and the finding of no associa-
tion by Salvesen et al25 in a much larger sample of
children, we conclude that the evidence is not
sufficient to claim any association of in utero
ultrasound exposure and delayed speech.
Dyslexia
In one study,4 425 children, ages 7 to 12 years,
exposed to ultrasound in utero were used as a
selection group to obtain 381 matched control
children to study the appearance of adverse
effects. A total of 17 outcome measures were
examined. Several of these were determined at
birth, including Apgar scores, gestational age,
head circumference, birth weight, length, con-
genital abnormalities, neonatal infection, and
congenital infection. The tests performed subse-
quently in the children included hearing, visual
acuity and color vision, cognitive function, and
behavior. The authors concluded, “No biologi-
cally significant differences between exposed
and unexposed children were found.”4 However,
of the 17 measures, the authors did note a signif-
icantly greater proportion (P < .01) of those chil-
dren exposed to ultrasound to be dyslexic on the
basis of a Gray Oral Reading Test. Statistical anal-
ysis by the authors indicated that given the
design of the study and the numerous end points
evaluated, it was possible that this was an inci-
dental finding. In addition, there were several
factors that could have contributed to the possi-
ble dyslexia finding. The exposure conditions
may not have reflected the output of modern
ultrasound systems, given that the fetal exami-
nations were performed from 1968 through
1972. However, the finding of potential dyslexia
was considered sufficient to prompt further
study. Subsequently, a long-term follow-up study
was performed on 2161 children who were
part of 2 Norwegian randomized trials.22,26
The end points included evaluation for dyslexia
along with 5 additional hypotheses, including an
examination of non–right-handedness (includ-
ed in a separate discussion here) said to be asso-
ciated with dyslexia. These studies27–29 included
the specific examination of 603 children with
tests for dyslexia, including spelling, reading, and
intelligence.27 There were no statistically signifi-
cant differences between children screened with
ultrasound and controls in teacher-reported
school performance in the third year for reading,
spelling, arithmetic, and overall performance.
Specific dyslexia tests showed no differences
between screened children and controls in read-
ing, spelling, and intelligence scores and no dis-
crepancy between intelligence and reading or
spelling. The rates of occurrence for dyslexia
were 21 of the 309 screened children (7%; 95% CI,
3%–10%) and 26 of the 294 controls (9%; 95% CI,
4%–12%). Given that the original finding of
dyslexia was not confirmed in subsequent ran-
domized controlled trials, it is considered unlike-
ly that dyslexia results from routine ultrasound
screening examinations. However, these studies
did raise the issue of laterality (in terms of hand-
edness), which is also discussed here.
Non–Right-Handedness
The first report of a possible link between prena-
tal exposure to ultrasound and subsequent
non–right-handedness in insonated children
was published in 1993 by Salvesen et al.29 The
acoustic outputs of the ultrasound instrumenta-
tion used are thought to have been around 1
mW/cm2. The authors stressed in their analysis
that the association was “only barely significant
at the 5% level, and the possibility of a chance
finding should be kept in mind.” Unknown con-
founding factors may have been present. The
authors recommended that no clinical conclu-
sions be made. When looking further at their
data, as a response to a letter to the editor, they
described that the association was restricted to
boys.30 A second group of researchers (which
included Salvesen, the main author of the first
study, but with the new study performed in
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Sweden as opposed to Norway) published simi-
lar findings of a statistically significant associa-
tion between ultrasound exposure in utero and
non–right-handedness in boys.5 The fact that
similar findings appear to be present in 2 differ-
ent populations seems to add weight to the pro-
posed finding. In 1999, Salvesen and Eik-Nes10
published a meta-analysis of these 2 studies and
of previously unreported results. No difference
was found in general, but a mild difference was
present when analyzing boys separately. A word
of caution is needed: the use of the term meta-
analysis is somewhat of a misnomer. Only 2 stud-
ies were included. It is generally accepted that a
meta-analysis should include at least 6 studies.
Four comparisons were reported: (1) an inten-
tion-to-treat analysis, comparing those random-
ly assigned to receive ultrasound versus those in
the nonultrasound group; (2) a further analysis
of the above, limited to male infants; (3) a com-
parison of those who were actually scanned ver-
sus those who were not, thus breaking the
original randomization of each trial; and (4) the
analysis in comparison 3 limited to male infants.
When analyzing the results, a small increase in
non–right-handedness appeared to be present in
male infants, but if one adjusts for sex subgroups,
wider CIs should be used (97.5% versus 95%), and
the OR 1 should be included in the CI, therefore
making the difference not statistically significant.
Other important points to consider: the studies
by Kieler et al5,31 were population based and
observational rather than randomized and con-
trolled, as was the study by Salvesen et al.29
Furthermore the authors stretched their findings
to describe non–right-handedness as brain dam-
age. No valid mechanistic explanation can
explain the findings. We conclude that, although
there may be a small increase in the incidence of
non–right-handedness in male infants, there is
not enough evidence to infer a direct effect on
brain structure or function or even that
non–right-handedness is an adverse effect.
Conclusions
In addition to the above, it must once more be
stressed that there has been no epidemiologic
study published on populations scanned after
1992, when regulations were altered and the
acoustic output of diagnostic instruments was
permitted to reach levels many times higher than
previously allowed (from 94 to 720 mW/cm2 spa-
tial-peak temporal-average intensity for fetal
applications). In several studies,22,27,29 levels
reported by the manufacturers were no more
than 1.5 W/cm2 spatial-peak temporal-peak
intensity. There are no epidemiologic studies
related to the output display standard (thermal
and mechanical indices) and clinical outcomes.
The safety of new technologies (harmonic imag-
ing, Doppler imaging [spectral and color], 3-
dimensional imaging, and the use of ultrasound
contrast agents) as well as that of probe self-heat-
ing32 needs to be investigated.
Major limitations of epidemiologic studies are
that (1) a testable hypothesis for causation of the
studied effect is not always apparent, and (2)
information about exposimetry (pulse parame-
ters and exposure duration) is almost never pre-
sented or known. These deficiencies need to be
rectified in future research to arrive at truly valid
and clinically meaningful results. While ultra-
sound may have bioeffects, based mainly on two
mechanisms of action (thermal and mechani-
cal), many uncertainties persist. These include,
among others, existence of a threshold or lack
thereof, importance of exposure duration (type
of examination, examiner’s skills, and multiple
examiners), influence of repeated scans (ques-
tion of cumulative doses), and biological
response differences secondary to tissue prop-
erties, susceptibility (eg, fetuses at different
gestational ages or brain versus bones) and
environment (eg, elevated temperature in the
mother or medical conditions complicating the
pregnancy). A further confounding factor is the
fact that major anomalies occur in 3% to 5% of
the general human population. An increment of
1% to 2% over this “background” incidence
would be a major clinical effect but might go
undetected as an individual finding in routine
clinical practice.
Epidemiologic evidence is thus not sufficient
to establish a causal relationship between ultra-
sound and adverse effects. Biological effects
have been shown using some forms of ultra-
sound in animal and in vitro models. Subtle or
transient effects in humans are possible, but
none have been consistently demonstrated so
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far; therefore, diagnostic ultrasound remains
without any known risk. Furthermore, while
not always relevant in an analysis of epidemi-
ologic data, risk-benefit issues are extremely
important in clinical practice. Because risks of
adverse effects appear so low and clinical
benefits so great, there is no justification to
withhold the prudent use of diagnostic ultra-
sound in medically indicated conditions. 
Appendix: An Epidemiology Primer
Measures of Disease Frequency
The first point to consider in any analysis of a
disease or a condition is its frequency. The two
basic parameters are prevalence and incidence.
Prevalence is the proportion of affected individ-
uals at a specific point in time (also known as
point prevalence). It is obtained by dividing the
total population into the number of affected indi-
viduals. Incidence is the frequency of new cases
over a particular measure of time. Further char-
acterization of incidence can include cumulative
incidence and incidence density. Cumulative
incidence describes the proportion of new
cases over a certain time period. This is
obtained by dividing the number of new cases
by the total at risk population during that time
period. Incidence density adds into the denomi-
nator the amount of time each person under
study has been at risk.
Study Design 
The next major area to discuss is the study type
or design. Epidemiologic studies may be obser-
vational or experimental. Observational studies
are further divided into descriptive (with cross-
sectional or longitudinal designs) and analytical
(with case-control or cohort designs depending
on whether the researcher begins with the dis-
ease or the exposure) studies. Descriptive studies
include case reports, case series, correlational
studies, and cross-sectional studies. These types
of studies are helpful in characterizing aspects of
exposure and outcome (who gets it, where, and
when), providing clues regarding etiology, assist-
ing with diagnosis and planning, and, from a
research standpoint, helping generate hypothe-
ses. They do not, however, provide information
regarding alternative explanations or compar-
isons between exposed and nonexposed.
Additionally, timing of exposure and develop-
ment of a disease or condition may not be clear.
These studies neither provide enough informa-
tion about multiple factors that may influence
suspected associations nor allow testing the
validity of potential associations.
Analytical studies test hypotheses including
those that are generated by descriptive studies.
Experimental studies include natural experiments
and randomized controlled trials. Longitudinal
descriptive, cohort analytical, and randomized
controlled trials are prospective (although cohort
studies may be retrospective), and case-control
studies and natural experiments are retrospective.
In case-control studies, the subjects are examined
once. In cohort studies, the subjects are followed
longitudinally over time and examined more
than once, usually prospectively but occasional-
ly retrospectively. Analytical studies involve
comparisons between groups of study partici-
pants with different exposures or outcome sta-
tuses. They generally allow for evaluation of the
timing of exposure relative to outcome. They
have, therefore, the ability to evaluate the sus-
pected presence of an association between expo-
sure and outcome frequency and prevalence.
Interventional studies provide the best opportu-
nity to parallel the goal of the experimental labo-
ratory studies, namely, to have participants be as
similar as possible in all characteristics, except
the exposure of interest (controlled by the inves-
tigator) so that an unbiased delineation of the
effect of that exposure can be made. This is the
most rigorous scientific approach, which can be
taken to accept the null hypothesis, that is, that
the exposure is not associated with the outcome
being studied. 
Measure of Association
In epidemiologic (and other) studies, several
parameters are used to measure association: RR,
OR, and attributable risk. The RR (also known as
the risk ratio or rate ratio) is the likelihood of
developing a disease or condition in an exposed
group compared with a nonexposed group. It is
equal to the ratio of the incidence of the outcome
in the exposed group (eg, disease) divided by the
incidence in the nonexposed group. It is used in
prospective cohort studies. Relative risks and
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ORs both provide estimates of excess risk. The OR
compares the odds of having been exposed
among positive cases to the odds of having been
exposed among controls. An association is present
if cases are more (or less) likely to have been
exposed than controls. This is relevant in retro-
spective case-control studies. Because both the
RR and OR are ratios, a value of 1 indicates no dif-
ference between subjects and controls. A ratio less
than 1.0 means protection from the outcome, and
a ratio greater than 1.0 indicates risk of the out-
come. Both are estimates of risk, based on the
sampled population. The true population risk
cannot be determined. Therefore, a range is calcu-
lated. This range describes our confidence that the
true risk to the entire population is within this
range; thus, it is called the CI. Generally, a 95% CI
is reported. This means that 95% of the time, the
true risk for the entire population will be within
the calculated range. The attributable risk is the
difference between the incidence of the disease/
condition in the exposed and unexposed. This
measure is often used to describe the amount of
disease that may be prevented by avoiding or
removing the exposure. It is important in deter-
mining the relevance of findings to specific clinical
decisions. Power is another major concept.
Statistical power refers to the strength of the con-
clusions that can be drawn from a particular set of
data. Four components can be distinguished: the
sample size (large enough to represent the entire
population), the effect size (significance of the fac-
tor that makes the population studied different
from the control), a or significance level (odds that
the observed effect is due to chance alone), and
power (odds that an effect will be observed when
present). Knowing 3 of the 4 elements allows for
calculation of the fourth, for example, the sample
size needed to observe a particular event with an
appropriate certainty of correlation with the expo-
sure. A weakness of epidemiology is that the
power needed to be worthy of clinical considera-
tion may be prohibitive. Indeed, the background
of birth defects in the general population is con-
sidered to be 3% to 5% of live births. If, clinically,
only 1% is added to the rate of malformation
induction, would it be detectable? The problem of
a large number of affected individuals combined
with a low ability to detect the increment is a
major epidemiologic challenge.
Bias
An important element that needs to be taken
into account when analyzing epidemiologic
studies is bias. Is the association that is being
observed truly related to the exposure, or was
there an error (sometimes very difficult to dis-
cern) in the methods? Bias is an error that may
lead to inaccurate estimation of the true associa-
tion between exposure and the disease/condi-
tion. Bias can be of several types. The major ones
to consider include selection (due to differences
in properties or characteristics between cases
selected or not), information recall (and its corre-
late, misclassification), diagnostic testing (cases
are tested more often than controls), and attri-
tion (potential study cases are eliminated, result-
ing in a higher number of “healthy” subjects).
Furthermore, one must be cautious that con-
founding factors are distinguished: some find-
ings may naturally be present because of certain
characteristics such as age and sex, which cause
some unbalance, potentially affecting results of
the research because of spurious associations. 
Statistical Precision
In certain studies, too few cases are described to
permit a meaningful estimate of the population
risk. Meta-analysis is an attempt to remediate
this problem. It is a method for combining results
of a number of small trials, addressing the same
questions but with different outcomes, to gain
statistical power for determining significant dif-
ferences that the smaller trials individually are
unable to detect. Single studies often cannot
detect or exclude small, although potentially
clinically significant, differences in the effects of
two alternatives, resulting in false-negative
results, or a type II error. The other type of error is
the false-positive, or type I, error, that is, showing
significant differences that, in fact, are due to
chance. Several independent separate studies
can be combined or integrated and analyzed
together, if considered similar enough, thus
reducing or eliminating type I and, more particu-
larly, type II errors. It is important to evaluate the
quality of the studies included in the analysis
because poor studies (such as one with poor
inclusion criteria or an obvious bias) can invali-
date the results of the meta-analysis. Although a
meta-analysis is not about original research, it
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may contain original findings. Other terms
describing this process are systematic review,
pooling of data, and quantitative synthesis.
These are more appropriate for descriptive anal-
ysis, while meta-analysis actually performs data
integration. Certain criteria need to be fulfilled,
similarly to any general statistical analysis: for-
mulation of a hypothesis, methods and criteria
for inclusion and exclusion, collection of data,
analysis, and reporting. Occasionally, the results
are reported in a graph form, with a vertical axis
representing the value 1 and ORs of the results of
different studies on either side of the 1, left being
less significant and right being more significant.
If these results cross the 1 line, the odds are not
significantly different.
A further major statistical concept to keep in
mind when looking at epidemiology is causality.
Epidemiology reveals associations between
exposure and observed effects. These may be
weak or strong, true or random, and statistically
significant or not. Epidemiology does not deter-
mine causality. Causality is judged by the strength
of the association, consistency, specificity, the
relationship in time, the biological gradient, bio-
logical plausibility, and experimental evidence.9
The last concept to consider when looking at epi-
demiologic studies is critical appraisal. This
includes categorizing the level of evidence and
weighing the risks and benefits of a given treat-
ment or diagnostic test based on individual
patient presentation and the quality of existing
evidence. The level of evidence varies between
level I, which is a randomized controlled trial
study, the reference standard, and level III, evi-
dence derived from reports by experts (opinions
rather than actual data). The RR and OR deter-
mine the association (or lack thereof) between an
exposure and an effect. It is vital to verify whether
the association is clinically relevant. Specific cri-
teria, as described by Bradford-Hill,33 consist of
the type of experiment, strength, consistency,
gradient, biological plausibility, specificity, coher-
ence, temporality, and analogy. All of the above
form the basis of looking for, analyzing, and using
research and its results, that is, evidence-based
medicine. When evaluating epidemiologic stud-
ies, critical appraisal allows one to categorize the
data in several levels to formulate an opinion
regarding validity and clinical relevance. The
highest level, the reference standard, is the ran-
domized controlled trial. The lowest is a report
from a committee of experts.
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